← All indications
Carcinoma, Pancreatic Ductal
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Drugs by status
Phase 2 trials (26)
- abemaciclib
- ags-1c4d4
- atu027
- brigatinib
- irinotecan
- ceritinib
- cobimetinib
- selinexor
- doxorubicin
- fluorouracil
- leucovorin
- colchicine
- ponatinib
- sulfur hexafluoride lipid-type a microspheres
- dendritic cells
- capecitabine
- parvovirus h-1
- cytotoxic t cells
- oxaliplatin
- etoposide
- thymalfasin
- neratinib maleate
- tislelizumab
- jab-3312
- jab-21822
- cd318-car-t cells
Organizations
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (14)
- Astellas
- FGK Clinical Research GmbH
- Silence Therapeutics GmbH
- Agensys, Inc.
- Oryx GmbH & Co. KG
- Changhai Hospital
- Cornell University
- Harvard University
- Norwegian University of Science and Technology
- University of Heidelberg
- Fudan University
- Granzer Regulatory Consulting & Services
- ImmunoGenes
- People's Liberation Army of China
Organization Involved with Phase 1 Indications (5)